Resolution of Protein-Losing Enteropathy With Low-Molecular Weight Heparin in an Adult Patient With Fontan Palliation

Annals of Thoracic Surgery

Volumn 84, Issue 6, 2007, Pages 2110-2112

  Bhagirath, Kapil M ^a   Tam, James W ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALPHA 1 ANTITRYPSIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ALBUMIN BLOOD LEVEL; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CASE REPORT; DOSE RESPONSE; FEMALE; FONTAN PROCEDURE; HEPARINIZATION; HUMAN; PRIORITY JOURNAL; PROTEIN LOSING GASTROENTEROPATHY; REMISSION;

ADULT; ANTICOAGULANTS; FEMALE; FONTAN PROCEDURE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PALLIATIVE CARE; PROTEIN-LOSING ENTEROPATHIES;

EID: 36248979276     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2007.06.064     Document Type: Article

References (12)

1. Feldt R.H., Driscoll D.J., Offord K.P., et al. Protein-losing enteropathy after the Fontan operation. J Thorac Cardiovasc Surg 112 (1996) 672-680
2. Lin W., Hwang M., Chung H., et al. Protein-losing enteropathy after the Fontan operation: clinical analysis of nine cases. Chang Gung Med J 29 (2006) 505-512
3. Rychik J., and Spray T.L. Strategies to treat protein-losing enteropathy. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 5 (2002) 3-11
4. Donnelly J.P., Rosenthal A., Castle V.P., and Holmes R.D. Reversal of protein-losing enteropathy with heparin therapy in three patients with univentricular hearts and Fontan palliation. J Pediatr 130 (1997) 474-478
5. Kelly A.M., Feldt R.H., Driscoll D.J., and Danielson G.K. Use of heparin in the treatment of protein-losing enteropathy after Fontan operation for complex congenital heart disease. Mayo Clin Proc 73 (1998) 777-779
6. Facchini M., Guldenschuh I., Turina J., Jenni R., Schalcher C., and Jost C.H. Resolution of protein-losing enteropathy with standard high molecular heparin and urokinase after Fontan repair in a patient with tricuspid atresia. J Cardiovasc Surg 41 (2000) 567-570
7. Tsuzuki T., Okada H., Takenaka R., et al. Reversal of protein-losing enteropathy with heparin therapy in an adult patient with congenital heart disease. Digestion 74 (2006) 206-207
8. Kim S., Park I., Song J., Lee J., and Shim W. Reversal of protein-losing enteropathy with calcium replacement in a patient after Fontan operation. Ann Thorac Surg 77 (2004) 1456-1457
9. Monagle P., Cochrane A., McCrindle B., Benson L., Williams W., and Andrew M. Editorial: thromboembolic complications after Fontan procedures-the role of prophylactic anticoagulation. J Thorac Cardiovasc Surg 115 (1998) 493-498
10. Jahangiri M., Ross D.B., Redington A.N., Lincoln C., and Shinebourne E.A. Thromboembolism after the Fontan procedure and its modifications. Ann Thorac Surg 58 (1994) 1409-1414
11. Adult Congenital Heart Disease in the Netherlands, Guidelines 2000. Working group "Congenitale Cardiologie bij Volwassenen": 64-67. Dutch Society of Cardiology, 2000.
12. Bode L., Murch S., and Freeze H. Heparan sulphate plays a central role in a dynamic in vitro model of protein-losing enteropathy. J Biol Chem 281 (2006) 7809-7815